JPMorgan analyst Richard Choe raised the firm’s price target on American Tower (AMT) to $255 from $250 and keeps an Overweight rating on the shares. The firm moved its price target to December 2026 from 2025 post the company’s Q2 report. American Tower is seeing “healthy” activity from its carrier customers and application volumes, but there has been a delay into revenue generation, which reduced the company’s outlook, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMT:
- HSBC downgrades American Tower on valuation after Q2 report
- American Tower downgraded to Hold from Buy at HSBC
- American Tower: Strong International Growth and Raised Guidance Justify Buy Rating Despite Mixed Q2 2025 Results
- American Tower’s Earnings Call: Positive Outlook Amid Challenges
- American Tower price target lowered to $245 from $250 at BMO Capital